Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on modern management of frailty

LIVE: Thursday 17th October 2024, 18:00-19:30 (CEST)

Frailty has a significant impact on health and wellbeing, especially in older adults. Join our experts to understand the factors that contribute to the development of frailty and find out how to manage the condition and reduce the risk of disability, dependency, and mortality.
ADVANCED SEARCH
Log in
Top
Current Pulmonology Reports

29-09-2024 | Positron Emission Tomography | REVIEW

Initial Staging of Lung Cancer with FDG PET/CT

Authors: Aysu Sinem Koc, Recep Savas

Published in: Current Pulmonology Reports

Login to get access

Abstract

Purpose of the review

Lung cancer is one of the leading causes of cancer death in industrialized nations, regardless of gender. Accurate staging improves patient treatment and prognosis. PET-CT is used extensively in lung cancer initial staging and restaging because it detects nodal and metastatic disease better than other imaging modalities allowing for better planning of surgery, radiotherapy and systemic therapy.

Recent development

New radiopharmaceuticals in development, e.g. FAPI, may have improved sensitivity for evaluating lung cancers, however its use is still being studied.

Summary

PET-CT is cost-effective for lung cancer evaluation. After PET-CT staging, 35% of CT-staged cases had an updated disease stage (typically an upstaged stage), requiring patient management modifications.
Literature
1.
Khaltaev N, Axelrod S. Global lung cancer mortality trends and lifestyle modifications: preliminary analysis. Chin Med J (Engl). 2020;133(13):1526–32.CrossRefPubMed
2.
Li C, Chen Q, Tian Y, et al. 68Ga-FAPI-04 PET/CT in Non-Small Cell Lung Cancer: Accurate Evaluation of Lymph Node Metastasis and Correlation with Fibroblast Activation Protein Expression. J Nucl Med. 2024;65(4):527–32.CrossRefPubMed
3.
Röhrich M, Daum J, Gutjahr E, et al. Diagnostic Potential of Supplemental Static and Dynamic 68Ga-FAPI-46 PET for Primary 18F-FDG-Negative Pulmonary Lesions. J Nucl Med. 2024;65, 6:872-879.
4.
Ceylan N, Doğan S, Kocaçelebi K, Savaş R, Çakan A, Çağrici U. Contrast enhanced CT versus integrated PET-CT in pre-operative nodal staging of non-small cell lung cancer. Diagn Interv Radiol. 2012;18(5):435–40.PubMed
5.
Archer JM, Truong MT, Shroff GS, Godoy MCB, Marom EM. Imaging of Lung Cancer Staging. Semin Respir Crit Care Med. 2022;43(6):862–73.CrossRefPubMed
6.
Zhi XY, Yu JM, Shi YK. Chinese guidelines on the diagnosis and treatment of primary lung cancer (2015 version) [published correction appears in Cancer. 2016 Jan 1;122(1):162]. Cancer. 2015;121
7.
Grgic A, Yüksel Y, Gröschel A, et al. Risk stratification of solitary pulmonary nodules by means of PET using (18)F-fluorodeoxyglucose and SUV quantification. Eur J Nucl Med Mol Imaging. 2010;37(6):1087–94.CrossRefPubMed
8.
Kligerman S, Digumarthy S. Staging of non–small cell lung cancer using integrated PET/CT. Am J Roentgenol. 2009;193(5):1203–11.CrossRef
9.
Liu J, Dong M, Sun X, Li W, Xing L, Yu J. Prognostic Value of 18F-FDG PET/CT in Surgical Non-Small Cell Lung Cancer: A Meta-Analysis. PLoS One. 2016;11, 1.
10.
Li H, Li L, Liu Y, Deng Y, Zhu Y, Huang L, Long T, Zeng L, Shu Y, Peng D. Predictive value of CT and 18F-FDG PET/CT features on spread through air space in lung adenocarcinoma. BMC Cancer. 2024Apr 8;24(1):434.CrossRefPubMedPubMedCentral
11.
Endoh H, Ichikawa A, Yamamoto R, et al. Prognostic impact of preoperative FDG-PET positive lymph nodes in lung cancer. Int J Clin Oncol. 2021;26(1):87–94.CrossRefPubMed
12.
Ravikanth R. Unilateral vocal cord paralysis secondary to central bronchogenic carcinoma. Indian J Med Paediatr Oncol. 2018;39:91–2.CrossRef
13.
Ruiter J, de Langen A, Monkhorst K, et al. Survival difference between patients with single versus multiple metastatic lymph nodes and the role of histology in pathological stage II-N1 non-small cell lung cancer. Acta Chir Belg. Published online February 28, 2024.
14.
15.
Sarswat S, Khan D, Sagar S, Kumar R. Role of 18 F-FDG PET/CT in the diagnosis of benign vs. malignant tumor thrombus. Nucl Med Commun. 2023;44, 8:726–731.
16.
Chassagnon G, Vakalopoulou M, Paragios N, et al. Artifcial intelligence applications for thoracic imaging. Eur J Radiol. 2020;123:108774.CrossRefPubMed
17.
Zhao H, Su Y, Lyu Z, Tian L, Xu P, Lin L, Han W, Fu P. Non-invasively Discriminating the Pathological Subtypes of Non-small Cell Lung Cancer with Pretreatment 18F-FDG PET/CT Using Deep Learning. Acad Radiol 2024;31(1):35–45.
18.
Beer L, Hochmair M, Haug AR, Schwabel B, Kifjak D, Wadsak W, vd. Comparison of RECIST, iRECIST, and PERCIST for the Evaluation of Response to PD-1/PD-L1 Blockade Therapy in Patients With Non–Small Cell Lung Cancer. Clin Nucl Med [Internet]. 2019;44, 7:535.
Metadata
Title
Initial Staging of Lung Cancer with FDG PET/CT
Authors
Aysu Sinem Koc
Recep Savas
Publication date
29-09-2024
Publisher
Springer US
Published in
Current Pulmonology Reports
Electronic ISSN: 2199-2428
DOI
https://doi.org/10.1007/s13665-024-00363-y

EASD 2024

‘Noninferior’ reduction of type 1 diabetes HbA1c by weekly insulin efsitora alfa

Weekly treatment with insulin efsitora is noninferior to daily insulin degludec for the reduction of HbA1c in adults with type 1 diabetes, show the findings of the QWINT-5 trial.

Read more

Weight loss with new obesity drug amycretin

Tirzepatide significantly reduces UACR in individuals with obesity and type 2 diabetes

Liraglutide reduces BMI for young children with obesity

» View more highlights on the EASD 2024 hub page

2024 ESC Congress

Noise pollution dangerous for heart health

Two studies underscore the adverse impact of noise pollution on the risk for and prognosis after myocardial infarction.

Read more

Post-TAVI follow up: deploying virtual assistants

Antihypertensives: more effective at morning or night?

Low Lp(a) levels unlikely to increase the risk of diabetes

» View more highlights on the 2024 ESC Congress hub page

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more
Image Credits